+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019 - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2019

  • Drug Pipelines
  • April 2019
  • 85 Pages
  • Global
From
Pharmaceutical Drugs Development Annual Review, Sales and Forecast, Key Trends and Competitive Analysis - Product Thumbnail Image

Pharmaceutical Drugs Development Annual Review, Sales and Forecast, Key Trends and Competitive Analysis

  • Report
  • June 2023
  • 46 Pages
  • Global
From
Investigation Report on Clopidogrel in China, 2018-2022 - Product Thumbnail Image

Investigation Report on Clopidogrel in China, 2018-2022

  • Report
  • July 2018
  • 30 Pages
  • China
From
Immunology Drugs Market Report Suite for the United States - 2018-2024 - Product Thumbnail Image

Immunology Drugs Market Report Suite for the United States - 2018-2024

  • Report
  • April 2018
  • United States
From
Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • Report
  • March 2019
  • 164 Pages
  • Global
From
Analyzing the Global Market for Active Pharmaceutical Ingredients 2018 - Product Thumbnail Image

Analyzing the Global Market for Active Pharmaceutical Ingredients 2018

  • Report
  • September 2018
  • 425 Pages
  • Global
From
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU - Product Thumbnail Image

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • Report
  • September 2018
  • 162 Pages
  • Global
From
2024 Bristol-Myers Squibb Full-Year Operating and Financial Review-SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

2024 Bristol-Myers Squibb Full-Year Operating and Financial Review-SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry

  • SWOT Analysis
  • January 2025
  • Global
From
Bristol-Myers Squibb Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Bristol-Myers Squibb Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2025
  • 50 Pages
From
Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • October 2024
  • 98 Pages
From
Comprehensive Report on Bristol-Myers Squibb, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Bristol-Myers Squibb, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Bristol-Myers Squibb Company - Company Profile and SWOT Analysis - Product Thumbnail Image

Bristol-Myers Squibb Company - Company Profile and SWOT Analysis

  • SWOT Analysis
  • January 2025
  • 75 Pages
From
Loading Indicator